Mirabella Financial Services LLP Purchases 11,425 Shares of CME Group Inc. $CME

Mirabella Financial Services LLP grew its position in CME Group Inc. (NASDAQ:CME) by 211.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,823 shares of the financial services provider’s stock after buying an additional 11,425 shares during the quarter. Mirabella Financial Services LLP’s holdings in CME Group were worth $4,536,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Caldwell Trust Co raised its position in CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group during the 3rd quarter worth $27,000. Financial Consulate Inc. bought a new stake in shares of CME Group during the 3rd quarter worth $28,000. Sagard Holdings Management Inc. acquired a new stake in CME Group in the second quarter valued at about $30,000. Finally, Corundum Trust Company INC bought a new position in CME Group in the third quarter valued at about $30,000. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $313.83 on Tuesday. CME Group Inc. has a fifty-two week low of $248.53 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The company has a market capitalization of $113.17 billion, a PE ratio of 28.12, a P/E/G ratio of 3.36 and a beta of 0.24. The company has a 50 day simple moving average of $296.58 and a two-hundred day simple moving average of $279.39.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. CME Group’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.52 EPS. Research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a $1.30 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio is currently 46.59%.

Insider Activity

In other CME Group news, Director William R. Shepard bought 251 shares of the business’s stock in a transaction dated Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director directly owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 748 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the transaction, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This represents a 21.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 5,248 shares of company stock valued at $1,616,700 over the last ninety days. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CME shares. Raymond James Financial reduced their price target on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. TD Cowen boosted their target price on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a report on Thursday, February 5th. Rothschild & Co Redburn raised their price objective on CME Group from $333.00 to $347.00 and gave the company a “neutral” rating in a report on Thursday, March 12th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $304.06.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.